GO Term | Evidence Code | PMID |
---|---|---|
tissue remodeling | ||
mononuclear cell migration | ||
proteolysis | ||
trophoblast giant cell differentiation | ||
negative regulation of cell-substrate adhesion |
GO Term | Evidence Code | PMID |
---|---|---|
external side of plasma membrane | ||
Schaffer collateral - CA1 synapse | ||
collagen-containing extracellular matrix | ||
extracellular region | ||
cell surface |
GO Term | Evidence Code | PMID |
---|---|---|
kinase binding | ||
signaling receptor binding | ||
enzyme binding | ||
protein-folding chaperone binding | ||
protease binding |
Gene Ontology |
---|
blood coagulation |
fibrinolysis |
hemostasis |
hydrolase activity |
proteolysis |
serine-type endopeptidase activity |
serine-type peptidase activity |
signaling receptor binding |
tissue remodeling |
InterPro |
---|
Kringle superfamily |
Kringle, conserved site |
Kringle-like fold |
Kringle |
PAN/Apple domain |
Peptidase S1, PA clan, chymotrypsin-like fold |
Peptidase S1, PA clan |
Peptidase S1A, chymotrypsin family |
Peptidase S1A, plasmin |
Serine proteases, trypsin domain |
DO ID | Disease Name | Source |
---|---|---|
DOID:0080600 | COVID-19 | |
DOID:0111592 | plasminogen deficiency type I | |
DOID:10159 | osteonecrosis | |
DOID:14735 | hereditary angioedema | |
DOID:2452 | thrombophilia | |
DOID:3490 | Noonan syndrome | |
DOID:6195 | conjunctivitis |
Species | Gene ID | OrthoDB | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|---|
101874700 | MELUD05212 | |||
101966400 | 43179_0:000ce1 | |||
101994518 | 79684_0:003884 | |||
102011248 | 34839_0:0020e6 | CHILA10824 | ||
102145643 | MACFA30923 | |||
102184723 | CAPHI30468 | |||
102424999 | MYOLU16787 | |||
102908135 | 230844_0:003f70 | |||
103036400 | ASTMX01191 | |||
103240838 | CHLSB03899 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024